Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors.

Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, Golla V, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2019 Sep 16. pii: S1078-1439(19)30334-5. doi: 10.1016/j.urolonc.2019.08.016. [Epub ahead of print]

PMID:
31537483
2.

Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.

Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2019 Sep;37(9):577.e9-577.e16. doi: 10.1016/j.urolonc.2019.03.009. Epub 2019 Mar 28.

PMID:
30930099
3.

Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.

Houlahan KE, Salmasi A, Sadun TY, Pooli A, Felker ER, Livingstone J, Huang V, Raman SS, Ahuja P, Sisk AE Jr, Boutros PC, Reiter RE.

Eur Urol. 2019 Jul;76(1):18-23. doi: 10.1016/j.eururo.2018.12.036. Epub 2019 Jan 24.

PMID:
30685078
4.

Urinary Cytokine Profile to Predict Response to Intravesical BCG with or without HS-410 Therapy in Patients with Non-muscle-invasive Bladder Cancer.

Salmasi A, Elashoff DA, Guo R, Upfill-Brown A, Rosser CJ, Rose JM, Giffin LC, Gonzalez LE, Chamie K.

Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1036-1044. doi: 10.1158/1055-9965.EPI-18-0893. Epub 2018 Dec 28.

PMID:
30593457
5.

PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.

Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE.

J Urol. 2019 Jan;201(1):91-97. doi: 10.1016/j.juro.2018.08.043.

PMID:
30577397
6.

Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.

Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, Maehara CK, Ahuja P, Faiena I, Pooli A, Salmasi A, Sisk A, Felker ER, Lu DSK, Reiter RE.

Eur Urol. 2019 May;75(5):712-720. doi: 10.1016/j.eururo.2018.11.031. Epub 2018 Dec 1.

PMID:
30509763
7.

Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better?

Pooli A, Salmasi A, Faiena I, Lenis AT, Johnson DC, Lebacle C, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2019 Jan;37(1):63-70. doi: 10.1016/j.urolonc.2018.10.018. Epub 2018 Nov 13.

PMID:
30446452
8.

Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.

Upfill-Brown A, Lenis AT, Faiena I, Salmasi AH, Johnson DC, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

World J Urol. 2019 Jun;37(6):1157-1164. doi: 10.1007/s00345-018-2506-1. Epub 2018 Sep 28.

PMID:
30267197
9.

Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.

Salmasi A, Faiena I, Lenis AT, Pooli A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2018 Dec;36(12):527.e13-527.e19. doi: 10.1016/j.urolonc.2018.08.009. Epub 2018 Sep 15.

PMID:
30228094
10.

PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.

Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE.

J Urol. 2019 Jan;201(1):91-97. doi: 10.1016/j.juro.2018.08.043.

PMID:
30142318
11.

Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center.

Salmasi A, Faiena I, Wu J, Sisk AE Jr, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE.

Urol Oncol. 2018 Sep;36(9):401.e19-401.e25. doi: 10.1016/j.urolonc.2018.06.006. Epub 2018 Jul 29.

PMID:
30064933
12.

Applying protective rectal tube in intestinal anastomosis.

Talaiezadeh A, Shoushtary MS, Salmasi AA, Afkhami MA.

Prz Gastroenterol. 2018;13(2):99-101. doi: 10.5114/pg.2018.76006. Epub 2018 May 25.

13.

Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy.

Faiena I, Salmasi A, Mendhiratta N, Lenis AT, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

World J Urol. 2018 Nov;36(11):1825-1833. doi: 10.1007/s00345-018-2327-2. Epub 2018 May 11.

PMID:
29752514
14.

A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.

Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE Jr, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, Reiter RE.

J Urol. 2018 Sep;200(3):564-572. doi: 10.1016/j.juro.2018.03.004. Epub 2018 Mar 7.

PMID:
29524506
15.

Re: Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

Faiena I, Salmasi A, Pantuck AJ, Drakaki A.

Eur Urol. 2018 Jun;73(6):981. doi: 10.1016/j.eururo.2018.01.023. Epub 2018 Feb 9. No abstract available.

PMID:
29433974
16.

Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy.

Salmasi A, Faiena I, Drakaki A, Pantuck AJ.

Eur Urol. 2018 Jul;74(1):119-121. doi: 10.1016/j.eururo.2018.01.036. Epub 2018 Feb 9. No abstract available.

PMID:
29433972
17.

Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.

Faiena I, Kim S, Farber N, Kwon YS, Shinder B, Patel N, Salmasi AH, Jang T, Singer EA, Kim WJ, Kim IY.

Oncotarget. 2017 Sep 28;8(65):109783-109790. doi: 10.18632/oncotarget.21297. eCollection 2017 Dec 12.

18.

Trends in urinary diversion after radical cystectomy for urothelial carcinoma.

Bachour K, Faiena I, Salmasi A, Lenis AT, Johnson DC, Pooli A, Drakaki A, Pantuck AJ, Chamie K.

World J Urol. 2018 Mar;36(3):409-416. doi: 10.1007/s00345-017-2169-3. Epub 2018 Jan 3.

PMID:
29299664
19.

Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.

Lenis AT, Salmasi AH, Donin NM, Faiena I, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun AS, Pantuck AJ, Chamie K.

Urol Oncol. 2018 Feb;36(2):78.e21-78.e28. doi: 10.1016/j.urolonc.2017.09.030. Epub 2017 Nov 8.

PMID:
29128421
20.

Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.

Faiena I, Salmasi A, Lenis AT, Donin NM, Johnson DC, Bachour K, Drakaki A, Belldegrun AS, Pantuck AJ, Chamie K.

Urol Oncol. 2018 Feb;36(2):79.e19-79.e26. doi: 10.1016/j.urolonc.2017.10.009. Epub 2017 Nov 2.

PMID:
29103965
21.

Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma.

Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun A, Pantuck A, Chamie K.

Urol Oncol. 2018 Jan;36(1):9.e1-9.e9. doi: 10.1016/j.urolonc.2017.09.001. Epub 2017 Oct 20.

PMID:
29066013
22.

Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013.

Faiena I, Tabakin A, Leow J, Patel N, Modi PK, Salmasi AH, Chung BI, Chang SL, Singer EA.

Can J Urol. 2017 Oct;24(5):8990-8997.

PMID:
28971785
23.

Anatomic and Molecular Imaging in Prostate Cancer.

Miller ET, Salmasi A, Reiter RE.

Cold Spring Harb Perspect Med. 2018 Mar 1;8(3). pii: a030619. doi: 10.1101/cshperspect.a030619. Review.

PMID:
28710256
24.

The ticking time bomb in lifestyle-related diseases among women in the Gulf Cooperation Council countries; review of systematic reviews.

Alshaikh MK, Filippidis FT, Al-Omar HA, Rawaf S, Majeed A, Salmasi AM.

BMC Public Health. 2017 Jun 2;17(1):536. doi: 10.1186/s12889-017-4331-7. Review.

25.

Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.

Lenis AT, Donin NM, Johnson DC, Faiena I, Salmasi A, Drakaki A, Belldegrun A, Pantuck A, Chamie K.

J Urol. 2018 Jan;199(1):43-52. doi: 10.1016/j.juro.2017.04.092. Epub 2017 May 4. Review.

26.

Hydatid Cyst of the Heart.

Noaman H, Rawaf S, Majeed A, Salmasi AM.

Angiology. 2017 Oct;68(9):765-768. doi: 10.1177/0003319717690093. Epub 2017 Jan 31.

27.

Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System.

Salmasi A, Lee GT, Patel N, Goyal R, Dinizo M, Kwon YS, Modi PK, Faiena I, Kim HJ, Lee N, Hannan JL, Kohn J, Kim IY.

J Sex Med. 2016 Dec;13(12):1834-1843. doi: 10.1016/j.jsxm.2016.10.003. Epub 2016 Nov 11. Erratum in: J Sex Med. 2017 Feb;14(2):284.

PMID:
27843073
28.

Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.

Davis R, Salmasi A, Koprowski C, Kim S, Kwon YS, Faiena I, Patel N, Elsamra SE, Kim IY.

Clin Genitourin Cancer. 2016 Dec;14(6):e617-e622. doi: 10.1016/j.clgc.2016.04.010. Epub 2016 Apr 22.

PMID:
27188968
29.

Renal Leiomyosarcoma: Case Report and Review of the Literature.

Kwon YS, Salmasi A, Han CS, Hon JD, Singer EA.

World J Nephrol Urol. 2015 Jun;4(2):213-217.

30.

Effect of Uncontrolled Diabetes on Outcomes After Cystectomy in Patients With Bladder Cancer: A Population-Based Study.

Faiena I, Dombrovskiy VY, Sultan RC, Salmasi AH, Singer EA, Weiss RE.

Clin Genitourin Cancer. 2016 Oct;14(5):e509-e514. doi: 10.1016/j.clgc.2016.02.004. Epub 2016 Feb 23.

PMID:
26997576
31.

Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.

Kwon YS, Ha YS, Modi PK, Salmasi A, Parihar JS, Patel N, Faiena I, May M, Lee DI, Llukani E, Patrick T, Rha KH, Ahlering T, Skarecky D, Ahn H, Choi SK, Park S, Jeon SS, Ou YC, Eun D, Manucha V, Albala D, Badani K, Yuh B, Ruel N, Kim TH, Kwon TG, Marchalik D, Hwang J, Kim WJ, Kim IY.

BMC Urol. 2015 Aug 1;15:79. doi: 10.1186/s12894-015-0070-1.

32.

Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy.

Faiena I, Dombrovskiy VY, Modi PK, Patel N, Patel R, Salmasi AH, Parihar JS, Singer EA, Kim IY.

Clin Genitourin Cancer. 2015 Oct;13(5):447-52. doi: 10.1016/j.clgc.2015.05.004. Epub 2015 May 28.

33.

They stole her teeth! An exploration of adults with developmental disability experiences with dental care.

Salmasi A, Harrison R, Brondani MA.

Spec Care Dentist. 2015 Sep;35(5):221-228. doi: 10.1111/scd.12115. Epub 2015 May 7.

PMID:
25951768
34.

Safety of Robot-Assisted Radical Prostatectomy with Pneumoperitoneum of 20 mm Hg: A Study of 751 Patients.

Modi PK, Kwon YS, Patel N, Dinizo M, Farber N, Zhao PT, Salmasi A, Parihar J, Ginsberg S, Ha YS, Kim IY.

J Endourol. 2015 Oct;29(10):1148-51. doi: 10.1089/end.2015.0094. Epub 2015 Jul 13.

PMID:
25891967
35.

Inadvertent foley catheterization of the ureter.

Modi PK, Salmasi AH, Perlmutter MA.

Can J Urol. 2014 Jun;21(3):7326-9. Review.

PMID:
24978365
36.

Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.

Ha YS, Kang DI, Kim JH, Joung JY, Yu J, Parihar JS, Salmasi AH, Horie S, Kim WJ, Yi Kim I.

Can J Urol. 2014 Jun;21(3):7290-7.

PMID:
24978359
37.

Prostate-specific antigen density toward a better cutoff to identify better candidates for active surveillance.

Ha YS, Yu J, Salmasi AH, Patel N, Parihar J, Singer EA, Kim JH, Kwon TG, Kim WJ, Kim IY.

Urology. 2014 Aug;84(2):365-71. doi: 10.1016/j.urology.2014.02.038. Epub 2014 Jun 10.

PMID:
24925834
38.

Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy.

Kang JH, Ha YS, Kim S, Yu J, Patel N, Parihar JS, Salmasi AH, Kim WJ, Kim IY.

BMC Urol. 2014 Apr 7;14:30. doi: 10.1186/1471-2490-14-30.

39.

Sphygmomanometer cuffs: a potential source of infection!

Zargaran D, Hardwick S, Adel R, Hill G, Stubbins D, Salmasi AM.

Angiology. 2015 Feb;66(2):118-21. doi: 10.1177/0003319714522855. Epub 2014 Feb 24.

PMID:
24569512
40.

Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy.

Woo SH, Kang DI, Ha YS, Salmasi AH, Kim JH, Lee DH, Kim WJ, Kim IY.

J Endourol. 2014 Feb;28(2):172-7. doi: 10.1089/end.2013.0304. Epub 2013 Oct 23.

PMID:
23987521
41.

Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance.

Ha YS, Salmasi A, Karellas M, Singer EA, Kim JH, Han M, Partin AW, Kim WJ, Lee DH, Kim IY.

Urology. 2013 Apr;81(4):831-5. doi: 10.1016/j.urology.2012.12.046. Epub 2013 Mar 7.

42.

Absence of prostatic growth in large cohort of adult female patients with congenital adrenal hyperplasia.

Doherty PJ, Friedman AA, Migeon CJ, Macura KJ, Salmasi AH, Lakshmanan Y.

J Urol. 2012 Oct;188(4 Suppl):1588-95. doi: 10.1016/j.juro.2012.02.029. Epub 2012 Aug 19.

PMID:
22910261
43.

Urological outcomes in the omphalocele exstrophy imperforate anus spinal defects (OEIS) complex: experience with 80 patients.

Phillips TM, Salmasi AH, Stec A, Novak TE, Gearhart JP, Mathews RI.

J Pediatr Urol. 2013 Jun;9(3):353-8. doi: 10.1016/j.jpurol.2012.04.017. Epub 2012 May 27.

PMID:
22640865
44.

Molecular effects of genistein on male urethral development.

Ross AE, Marchionni L, Phillips TM, Miller RM, Hurley PJ, Simons BW, Salmasi AH, Schaeffer AJ, Gearhart JP, Schaeffer EM.

J Urol. 2011 May;185(5):1894-8. doi: 10.1016/j.juro.2010.12.095. Epub 2011 Mar 21.

45.

Primary Actinomycosis of the Breast Presenting as a Breast Mass.

Salmasi A, Asgari M, Khodadadi N, Rezaee A.

Breast Care (Basel). 2010;5(2):105-107. Epub 2010 Apr 9.

46.

Cholestasis induced nephrotoxicity: the role of endogenous opioids.

Deroee AF, Nezami BG, Mehr SE, Hosseini R, Salmasi AH, Talab SS, Jahanzad I, Dehpour AR.

Life Sci. 2010 Mar 27;86(13-14):488-92. doi: 10.1016/j.lfs.2010.02.005. Epub 2010 Feb 12.

PMID:
20153756
47.

Oligodendroglial and pan-neural crest expression of Cre recombinase directed by Sox10 enhancer.

Stine ZE, Huynh JL, Loftus SK, Gorkin DU, Salmasi AH, Novak T, Purves T, Miller RA, Antonellis A, Gearhart JP, Pavan WJ, McCallion AS.

Genesis. 2009 Nov;47(11):765-70. doi: 10.1002/dvg.20559.

48.

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.

Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, Mendell JT, Lupold SE.

Cancer Res. 2009 Sep 15;69(18):7165-9. doi: 10.1158/0008-5472.CAN-09-1448. Epub 2009 Sep 8.

49.

Atrial septal aneurysm and patent foramen ovale are less prevalent in the Indo-Asian than in the Caucasian or Afro-Caribbean population.

Salmasi AM, Salmasi H, Rawlins S, Baakil M, Dancy M.

Angiology. 2010 Feb;61(2):205-10. doi: 10.1177/0003319709339590. Epub 2009 Sep 2.

PMID:
19729369
50.

Bladder neck transection for intractable pediatric urinary incontinence.

Novak TE, Salmasi AH, Lakshmanan Y, Mathews RI, Gearhart JP.

J Urol. 2009 Jan;181(1):310-4; discussion 314. doi: 10.1016/j.juro.2008.09.036. Epub 2008 Nov 14.

PMID:
19013617

Supplemental Content

Loading ...
Support Center